Screener / SEC EDGAR /CIK 0000814453 /10-K filed Feb 13, 2026, compared with Feb 14, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Materials · Plastics Products

Newell Brands Inc. NWL

Compare with peers Embed
The 10-K against last year's

148 changes: 22 added, 37 removed, 87 reworded, 2 quiet changes

10-K Feb 13, 2026 vs Feb 14, 2025

10-K 0000814453-26-000008 (Feb 13, 2026) vs 10-K 0000814453-25-000008 (Feb 14, 2025) Not compared: Legal Proceedings, Accounting Policies.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

123 paragraphs · 7 new · 28 reworded · 5 gone · 10-K Feb 13, 2026 against Feb 14, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 95 · 48% changed Every version of it
The Company is subject to various federal, state and foreign laws and regulations. As further described in Footnote 18 of the Notes to the Consolidated Financial Statements, the Company is also subject to third party litigation. The potential outcomes of third-party litigation, if insured, could exceed policy limits, resulting in significant costs and expenses. The Company could be responsible for any settlement or judgment over the amount of available insurance coverage or for the entire settlement or judgment, if not insured. The Company is also subject to formal and informal regulatory and governmental examinations, subpoenas, requests for documents, testimony or information, inquiries, investigations, threatened legal actions and proceedings. For example, in 2023, the Company entered into a settlement with the SEC, which concluded an investigation primarily relating to the Company’s sales practices and certain accounting matters between the third quarter of fiscal year 2016 and second quarter of fiscal year 2017. Under the terms of the settlement, the Company neither admitted nor denied the SEC’s findings and agreed to pay a civil penalty of approximately $13 million. Responding to governmental investigations, voluntary document requests, subpoenas or actions by regulatory bodies is time-consuming, expensive and disruptive to the Company’s operations and could divert the attention of management and key personnel from the Company’s business operations.
Paragraph 77 · 46% changed Every version of it
For example, the Company’s credit ratings were downgraded in both 2025 and 2024 and 2023 by each of Moody’s Corporation (“Moody’s”) and S&P Global Inc. (“S&P”) which resulted in a coupon step-up of certain of the Company’s outstanding senior notes. In addition, credit ratings can also affect the terms of debt agreements to include more restrictive covenants which may further restrict our business operations or limit our ability to raise additional capital due to our covenant restrictions then in effect. For example, in November 2024, the Company issued $750 million of aggregate principal amount of 6.375% senior notes due 2030 and $500 million of aggregate principal amount of 6.625% senior notes due 2032, and such notes contain covenants that are more restrictive than the senior notes that the Company has historically issued. There is no guarantee that debt or equity financings will be available in the future to fund future acquisitions, developments, or general operating expenses, or that such financing will be available on terms consistent with our historical agreements or expectations. See Liquidity and Capital Resources in Item 7 and Footnote 9 of the Notes to the Consolidated Financial Statements for further discussion.
Paragraph 78 · 32% changed Every version of it
For example, the Company’s credit ratings were downgraded in both 2024 and 2023 by each of Moody’s Corporation and S&P Global Inc. which resulted in a coupon step-up of certain of the Company’s outstanding senior notes. In addition, credit ratings can also affect the terms of debt agreements to include more restrictive covenants which may further restrict our business operations or limit our ability to raise additional capital due to our covenant restrictions then in effect. For example, in November 2024, the Company issued $750 million of aggregate principal amount of 6.375% senior notes due 2030 and $500 million of aggregate principal amount of 6.625% senior notes due 2032, and such in May 2025, the Company completed the offering and sale of $1.25 billion of 8.500% senior notes contain due 2028 (collectively the “Notes”). These Notes include covenants that are more restrictive than limit the senior notes that ability of the Company has historically issued. and its subsidiaries to incur or guarantee additional debt, create or permit certain liens, redeem or repurchase certain debt, consummate certain asset sales, make certain loans and investments, consolidate, merge or sell all or substantially all of the Company and its subsidiaries assets, enter into certain transactions with affiliates and pay distributions on, or redeem or repurchase the Company’s capital stock, subject in each case to certain qualifications and exceptions, including the termination of certain of these covenants upon the Notes receiving investment grade credit ratings. There is no guarantee that debt or equity financings will be available in the future to fund future acquisitions, developments, or general operating expenses, or that such financing will be available on terms consistent with our historical agreements or expectations. See Liquidity and Capital Resources in Item 7 and Footnote 9 8 of the Notes to the Consolidated Financial Statements for further discussion.
Paragraph 37 · 28% changed Every version of it
The Company may face particular data protection and privacy risks in connection with the European Union’s Global Data Protection Regulation, the California Consumer Privacy Act and other privacy laws and regulations. regulations globally.
Paragraph 109 · 25% changed Every version of it
The Company’s product liability insurance program is an occurrence-based program based on its current and historical claims experience and the availability and cost of insurance. The Company currently either self-insures or administers a high retention insurance program for most product liability risks. The Company cannot give assurance that its future product liability experience will be consistent with its past experience or that claims and awards subject to self-insured retention will not be material. See Footnote 18 of the Notes to Consolidated Financial Statements for a further discussion of these and other regulatory and litigation-related matters.
Paragraph 110 · 25% changed Every version of it
The Company’s product liability insurance program is an occurrence-based program based on its current and historical claims experience and the availability and cost of insurance. The Company currently either self-insures or administers a high retention insurance program for most product liability risks. The Company cannot give assurance that its future product liability experience will be consistent with its past experience or that claims and awards subject to self-insured retention will not be material. See Footnote 18 17 of the Notes to Consolidated Financial Statements for a further discussion of these and other regulatory and litigation-related matters.
Paragraph 31 · 24% changed Every version of it
The Company’s use of artificial intelligence (“AI”) AI tools in its operations and systems poses inherent risk and could adversely affect the Company’s operations and financial conditions. The Company’s success may increasingly become dependent on its ability to effectively leverage AI to support its operational efficiencies, such as in supply chain and support functions, and its product development and marketing capabilities. The Company may be outpaced by its competitors in their more successful or earlier adoption of AI solutions, which could negatively affect the Company’s commercial competitiveness. Use of AI exposes the Company to risks that such AI solutions may be deficient, produce inaccurate or misleading output, become inoperable or subject the Company to cybersecurity and data privacy breaches, all of which could lead to operational disruptions, flawed decision-making, increased costs, and an inhibited ability to improve product development and marketing through the use of AI, and could impact the Company’s operational effectiveness and financial condition. Additionally, the use of certain AI solutions could put the Company’s own information and intellectual property rights at risk or expose the Company to risk of infringing third parties’ intellectual property or other rights. The global legal, regulatory, and ethical landscape surrounding AI is rapidly evolving and remains uncertain, which creates continued compliance risk and may incur additional operational costs associated with the Company’s use of AI, may limit the Company’s ability to fully develop or use AI solutions as intended, and may further cause legal repercussions and brand or reputational harm to the Company.
Paragraph 43 · 23% changed Every version of it
Specifically, evolving Evolving trade policies could continue to make sourcing products from foreign countries more difficult and costly, as the Company sources a significant amount of its products from outside of the U.S. For example, in early In 2025, the current U.S. presidential administration announced significant and/or imposed a series of new tariffs on foreign imports into the U.S., specifically including without limitation significant tariffs on products manufactured in China. Tariffs on imports into the U.S., most significantly from Mexico and Canada, all of which were subsequently postponed prior to becoming effective, and China, and has proposed additional new retaliatory tariffs that may be implemented in the future. Given the Company’s reliance upon non-domestic suppliers, any significant changes to on exports from the U.S. to other countries, have increased costs for the Company and could impact the level of trade policies (and those between the U.S. and its various trading partners around the globe in general. The Company continues to deploy a mitigation strategy designed to offset the impact of other countries this tariff exposure through a number of actions, including pricing, productivity and in response) some cases relocation of manufacturing. However, the rate or changes without sufficient notice may cause a material adverse effect on its ability to source products from other countries or significantly increase the costs of obtaining such products, which could result in a material adverse effect on our financial results. The extent and duration of increased these tariffs and the resulting impact on general economic conditions and on our business are uncertain and depend on various factors, such as negotiations between the U.S. and affected countries, the responses of other countries or regions, exemptions or exclusions that may be granted, availability and cost of alternative sources of supply, and demand for our products in affected markets. Any markets, and there can be no assurance as to the extent to which the Company will be able to offset the impact through mitigation actions. Given the Company’s reliance upon non-domestic suppliers, new or additional tariffs on goods imported to the U.S. from China, Mexico, Canada, Mexico or other countries, or products imported into the European Union or other non-U.S. markets, could also or other significant changes to the U.S. trade policies (and those of other countries in response) or changes without sufficient notice may cause a material adverse effect on the Company’s ability to source products from other countries or significantly increase the cost costs of some of obtaining such products, which could result in a material adverse effect on our products and reduce our margins. financial results.

MD&A

135 paragraphs · 15 new · 71 reworded · 32 gone · 10-K Feb 13, 2026 against Feb 14, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 53 · 49% changed
As of December 31, 2024, the Company is a party to a $1.0 billion Credit Revolver maturing in August 2027. The Credit Revolver requires compliance with certain financial covenants. On February 7, 2024, the Company, certain of its subsidiaries, as subsidiary borrowers, and certain of its subsidiaries, as subsidiary guarantors (the “Guarantors”), entered into a Second Amendment to the Credit Revolver. The Second Amendment among other things, reduced the commitments of the lenders from $1.5 billion to $1.0 billion, replaced the Company’s existing financial covenants with new financial covenants, required the Company and the Guarantors to guarantee all obligations under the Credit Revolver, and required the Company and the other Guarantors to grant a lien and security interest in certain of its assets. A failure to maintain the Company’s financial covenants and to subsequently remedy a default would impair its ability to borrow under the Credit Revolver and potentially subject the Company to cross-default and acceleration provisions in its debt documents. The Credit Revolver provides for the issuance of up to $150 million of letters of credit, so long as there is sufficient availability for borrowing under the Credit Revolver. At December 31, 2024, 2025, the Company had $40 million of outstanding borrowings under the Credit Revolver and approximately $35 $37 million of outstanding standby letters of credit issued against the Credit Revolver, with Revolver and $130 million of outstanding borrowings under the Credit Revolver resulting in a net availability of approximately $925 $685 million. Availability under the Credit Revolver is subject to change in accordance with the terms thereof, including in response to changes to the Company’s pledged collateral value or outstanding borrowings and letters of credit under the Credit Revolver.
Paragraph 35 · 47% changed
Operating loss for 2024 2025 was $86 $25 million as compared to $83 $86 million in 2023. 2024. The decline improvement was primarily due to lower higher gross profit of $26 million, caused by unfavorable fixed cost leverage associated with lower sales volume and inflation, partially offset $31 million driven primarily by gross productivity, favorable pricing actions and savings mix. Savings from restructuring actions and absence of a non-cash impairment charge of $22 million recorded in the prior year. There were no non-cash impairment charges recorded during 2024. See Footnote 7 of the Notes also contributed to the Consolidated Financial Statements for further information. improvement of operating results.
Paragraph 31 · 47% changed
Operating loss for 2024 was $2 unfavorably impacted by $15 million as compared to operating income of $37 million in the prior year. The decline in operating results is primarily due to higher non-cash impairment charges, charges related to indefinite-lived tradenames (see Footnote 6 of $275 million, compared the Notes to a charge Consolidated Financial Statements for further information) and $15 million of $76 million during 2023, higher advertising and promotion costs of $18 million, additional amortization of certain tradenames of $17 million and inflation. costs. These unfavorable factors were partially offset by improvement of $134 million in gross profit, mainly due to productivity, lower savings from restructuring charges of $41 million and release of a bad debt reserve due to a recovery of a receivable from an international customer of $9 million. See Footnote 7 of the Notes actions related to the Consolidated Financial Statements for further information on non-cash impairment charge and additional amortization of tradenames. Realignment Plan.
Paragraph 86 · 45% changed
During the fourth quarter of 2024, 2025, in conjunction with its annual impairment testing, there were no goodwill impairment charges recorded as a result of the Company recorded non-cash impairment charge of $85 million associated with one tradename quantitative goodwill assessments. However, the Commercial reporting unit in the H&CS segment, as the had a fair value within 10% of its associated carrying value exceeded the fair value. The decline in the fair value of the tradename in the H&CS segment was the result of Commercial reporting unit resulted primarily from a downward revision of forecasted revenue mainly cash flows and an increase in the reporting unit’s discount rate, primarily due to a distribution loss, which an increased risk premium applied to enable reconciliation to the Company was informed of during Company's total enterprise value, given the fourth quarter of 2024. decline in the Company’s stock price since the last annual impairment test. A hypothetical 10% reduction in the forecasted revenue earnings before interest, taxes, depreciation and residual (excess) cash flows amortization used in the excess earnings method applied in determining discounted cash flows to estimate the fair value of to the tradename Commercial reporting unit would have resulted in an incremental impairment charge on the H&CS segment of $22 approximately $131 million against its goodwill carrying value of $747 million. During the third quarter of 2024, the Company concluded that triggering events had occurred for indefinite-lived tradenames in the H&CS and L&D segments, as a result of downward revisions of forecasted cash flows primarily due to lower volume and profitability expectations. The Company performed quantitative impairment tests and determined that the indefinite-lived tradenames in the H&CS and L&D segments were impaired. During the third quarter of 2024, the Company recorded non-cash impairment charges of $190 million and $70 million for the indefinite-lived tradenames in the H&CS and in the L&D segments, respectively, as the carrying values exceeded their fair values.
Paragraph 92 · 44% changed
During the fourth quarter of 2024, 2025, in conjunction with its annual impairment testing, the Company recorded non-cash impairment charges of $163 million and $127 million associated with two tradenames in the H&CS segment and $50 million associated with one tradename in the L&D segment had a fair value within 10% of its associated segment, as the carrying value of $135 million. A hypothetical 10% reduction in the forecasted revenue used in the relief from royalty method in determining values exceeded the fair value of the tradename would have resulted in an impairment charge of $10 million in the L&D segment. values.
Paragraph 93 · 43% changed
During the fourth quarter of 2024, in conjunction with its annual impairment testing, the Company recorded non-cash impairment charge of $85 million associated with one tradename in the H&CS segment, as the carrying value exceeded the fair value. The decline in the fair value of the tradename tradenames in the H&CS segment and L&D segments resulting in the aforementioned non-cash impairment charges was the result of a downward revision of forecasted revenue mainly cashflows and an increase in the tradenames’ discount rates, primarily due to a distribution loss, which increased risk premiums applied to enable reconciliation to the Company was informed of during Company's total enterprise value, given the fourth quarter of 2024. decline in the Company’s stock price since the last annual impairment test. A hypothetical 10% reduction in the forecasted revenue and residual (excess) cash flows used in the excess earnings method applied in determining the fair value of each tradename would have resulted in an incremental non-cash impairment charge in the H&CS segment of $19 million and $9 million, for each tradename. A hypothetical 10% reduction in the forecasted revenue used in the relief from royalty method in determining the fair value of the tradename would have resulted in an incremental non-cash impairment charge on the H&CS segment of $22 million. During the third quarter of 2024, the Company concluded that triggering events had occurred for indefinite-lived tradenames in the H&CS and L&D segments, as a result of downward revisions of forecasted cash flows primarily due to lower volume and profitability expectations. The Company performed quantitative impairment tests and determined that the indefinite-lived tradenames in the H&CS and L&D segments were impaired. During the third quarter of 2024, the Company recorded non-cash impairment charges of $190 million and $70 million for the indefinite-lived tradenames in the H&CS and in the L&D segments, respectively, as the carrying values exceeded their fair values. segment of $1 million.
Paragraph 45 · 42% changed
The change in net cash used in financing activities in 2024 was primarily due to lower quarterly dividend payment in higher utilization of the Credit Revolver during the current year and the period-over-period change in debt. year.
Paragraph 43 · 40% changed
The change in net cash provided by operating activities for 2023 2025, was primarily reflects a reduction driven by lower cash generated from accounts receivable, due to lower net sales and timing of working capital collections, cash impact of additional tariffs and lower higher cash incentive compensation payments in 2023, 2025. These were partially offset by impact improvement in inventory levels and timing of operating loss and higher vendor payments as well as lower restructuring payments. payments during the year.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors283 words changed in this paragraph; it is 51% similar to last year's version.
Specifically, evolving Evolving trade policies could continue to make sourcing products from foreign countries more difficult and costly, as the Company sources a significant amount of its products from outside of the U.S. For example, in early In 2025, the current U.S. presidential administration announced significant and/or imposed a series of new tariffs on foreign imports into the U.S., specifically including without limitation significant tariffs on products manufactured in China. Tariffs on imports into the U.S., most significantly from Mexico and Canada, all of which were subsequently postponed prior to becoming effective, and China, and has proposed additional new retaliatory tariffs that may be implemented in the future. Given the Company’s reliance upon non-domestic suppliers, any significant changes to on exports from the U.S. to other countries, have increased costs for the Company and could impact the level of trade policies (and those between the U.S. and its various trading partners around the globe in general. The Company continues to deploy a mitigation strategy designed to offset the impact of other countries this tariff exposure through a number of actions, including pricing, productivity and in response) some cases relocation of manufacturing. However, the rate or changes without sufficient notice may cause a material adverse effect on its ability to source products from other countries or significantly increase the costs of obtaining such products, which could result in a material adverse effect on our financial results. The extent and duration of increased these tariffs and the resulting impact on general economic conditions and on our business are uncertain and depend on various factors, such as negotiations between the U.S. and affected countries, the responses of other countries or regions, exemptions or exclusions that may be granted, availability and cost of alternative sources of supply, and demand for our products in affected markets. Any markets, and there can be no assurance as to the extent to which the Company will be able to offset the impact through mitigation actions. Given the Company’s reliance upon non-domestic suppliers, new or additional tariffs on goods imported to the U.S. from China, Mexico, Canada, Mexico or other countries, or products imported into the European Union or other non-U.S. markets, could also or other significant changes to the U.S. trade policies (and those of other countries in response) or changes without sufficient notice may cause a material adverse effect on the Company’s ability to source products from other countries or significantly increase the cost costs of some of obtaining such products, which could result in a material adverse effect on our products and reduce our margins. financial results.

Source: Item 1A, 10-K 0000814453-26-000008 vs Item 1A, 10-K 0000814453-25-000008

MD&A252 words changed in this paragraph; it is 34% similar to last year's version.
During the fourth quarter of 2024, in conjunction with its annual impairment testing, the Company recorded non-cash impairment charge of $85 million associated with one tradename in the H&CS segment, as the carrying value exceeded the fair value. The decline in the fair value of the tradename tradenames in the H&CS segment and L&D segments resulting in the aforementioned non-cash impairment charges was the result of a downward revision of forecasted revenue mainly cashflows and an increase in the tradenames’ discount rates, primarily due to a distribution loss, which increased risk premiums applied to enable reconciliation to the Company was informed of during Company's total enterprise value, given the fourth quarter of 2024. decline in the Company’s stock price since the last annual impairment test. A hypothetical 10% reduction in the forecasted revenue and residual (excess) cash flows used in the excess earnings method applied in determining the fair value of each tradename would have resulted in an incremental non-cash impairment charge in the H&CS segment of $19 million and $9 million, for each tradename. A hypothetical 10% reduction in the forecasted revenue used in the relief from royalty method in determining the fair value of the tradename would have resulted in an incremental non-cash impairment charge on the H&CS segment of $22 million. During the third quarter of 2024, the Company concluded that triggering events had occurred for indefinite-lived tradenames in the H&CS and L&D segments, as a result of downward revisions of forecasted cash flows primarily due to lower volume and profitability expectations. The Company performed quantitative impairment tests and determined that the indefinite-lived tradenames in the H&CS and L&D segments were impaired. During the third quarter of 2024, the Company recorded non-cash impairment charges of $190 million and $70 million for the indefinite-lived tradenames in the H&CS and in the L&D segments, respectively, as the carrying values exceeded their fair values. segment of $1 million.

Source: Item 7, 10-K 0000814453-26-000008 vs Item 7, 10-K 0000814453-25-000008

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of NWL's Risk Factors and MD&A, 10-K Feb 13, 2026 against 10-K Feb 14, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
products or line extensions could cause a decline in sales of the Company’s existing products. If new product development and commercialization efforts are not successful, the Company’s financial results could be adversely affected.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedRisk Factors
The Company’s operations and financial condition can be adversely impacted by global macroeconomic environment, including the impact of tariffs imposed by the U.S. and retaliatory tariffs imposed by other countries.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedRisk Factors
The Company’s ability to attract, retain and develop critical talent, including readiness for emerging technologies such as AI, is essential to executing its strategic objectives and sustaining long-term performance.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedRisk Factors
The Company’s success depends significantly on the continued contributions of executive leadership and other key personnel. The loss of the services of one or more of these individuals could materially and adversely affect the Company’s business, financial condition, and operating results. Additionally, maintaining a pipeline of highly skilled talent across all levels of the organization is critical as global competition intensifies and workforce expectations evolve, including remote work flexibility and technology-driven roles. Failure to attract, retain, or upskill employees—particularly in areas requiring AI proficiency, could impair our ability to innovate, adapt to market changes, and achieve operational goals.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedRisk Factors
The Company is a party to a $1.00 billion credit revolver maturing in August 2027 (the “Credit Revolver”), which requires compliance with certain financial covenants (as more fully described in Item 7-Management’s Discussion and Analysis of Financial Condition and Results of Operations). The failure of the Company to achieve anticipated financial results at any point during the term of the Credit Revolver, due to an economic downturn or otherwise, could result in a failure to satisfy one of more financial covenants under the Credit Revolver. The Company’s ability to continue to comply with these financial covenants is dependent upon the Company’s future operating and financial performance, which may be affected by economic conditions and other factors beyond our control. A failure to maintain the Company’s financial covenants and to subsequently remedy a default would impair our ability to borrow under the Credit Revolver and, absent a waiver of such default by the lenders under the Credit Revolver or an amendment or replacement of the Credit Revolver with alternative financing, potentially subject the Company to cross-default and acceleration provisions in its debt documents, which would have a significant adverse effect on the Company’s business, financial condition and operating results.
Read it in 10-K Feb 13, 2026 at sec.gov
RemovedRisk Factors
The Company’s ability to successfully execute its turnaround plan and its future performance depends in significant part upon the continued service of its executive officers and other key leaders. The loss of the services of one or more executive officers or other key employees could have a material adverse effect on the Company’s business, prospects, financial condition and results of operations. The Company’s success also depends, in part, on its continuing ability to attract, retain and develop highly qualified talent deeper in the organization.
Read it in 10-K Feb 14, 2025 at sec.gov
Show the other 54
RemovedRisk Factors
Global competition for talent is intense and has increased in recent years amidst emerging labor trends, including but not limited to expanded remote work options. There can be no assurance that the Company can attract, engage or retain its key employees or highly qualified talent in the future.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedRisk Factors
Damage to the Company’s reputation or a loss of consumer confidence in the Company’s brands could adversely affect the Company’s business, results of operations, cash flows and financial condition as well as require resources to repair the harm.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedRisk Factors
current income tax impact of Pillar Two is immaterial, however we will continue to monitor both U.S. and international legislative developments to assess for any potential impacts.
Read it in 10-K Feb 14, 2025 at sec.gov
RewordedRisk Factors
The extent and However, the rate or duration of increased these tariffs and the resulting impact on general economic conditions and on our business are uncertain and depend on various factors, such as negotiations between the U.S. and affected countries, the responses of other countries or regions, exemptions or exclusions that may be granted, availability and cost of alternative sources of supply, and demand for our products in affected markets. markets, and there can be no assurance as to the extent to which the Company will be able to offset the impact through mitigation actions.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
Given the Company’s reliance upon non-domestic suppliers, any new or additional tariffs on goods imported to the U.S. from China, Mexico or other countries, or products imported into the European Union or other non-U.S. markets, or other significant changes to the U.S. trade policies (and those of other countries in response) or changes without sufficient notice may cause a material adverse effect on its the Company’s ability to source products from other countries or significantly increase the costs of obtaining such products, which could result in a material adverse effect on our financial results.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
For example, in November 2024, the Company issued $750 million of aggregate principal amount of 6.375% senior notes due 2030 and $500 million of aggregate principal amount of 6.625% senior notes due 2032, and such notes contain covenants that are more restrictive than in May 2025, the Company completed the offering and sale of $1.25 billion of 8.500% senior notes that due 2028 (collectively the Company has historically issued. “Notes”).
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
In addition, credit ratings can also affect the terms of debt agreements to include more restrictive covenants which may further restrict our business operations or limit our ability to raise additional capital due to our covenant restrictions then in effect.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
For example, the Company’s credit ratings were downgraded in both 2024 and 2023 by each of Moody’s Corporation and S&P Global Inc. (“S&P”) which resulted in a coupon step-up of certain of the Company’s outstanding senior notes.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
For example, the Company’s credit ratings were downgraded in both 2025 and 2024 and 2023 by each of Moody’s Corporation (“Moody’s”) and S&P Global Inc. which resulted in a coupon step-up of certain of the Company’s outstanding senior notes.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
The Company may face particular data protection and privacy risks in connection with the European Union’s Global Data Protection Regulation, the California Consumer Privacy Act and other privacy laws and regulations. regulations globally.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
Our internal control over financial reporting may not prevent or detect misstatements because of its inherent limitations, including the possibility of human error, the circumvention or overriding of controls, or fraud.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
These laws and regulations may grant, among other things, individual rights to access and delete personal information, information and the right to opt out of the sale of personal information. information, causing the Company to incur costs and operational inefficiencies.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
From time to time, the Company announces certain initiatives regarding its focus areas, some of which may be required in accordance with applicable laws, and which may include environmental matters, human capital, sustainability, packaging, responsible sourcing and social investments.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
At December 31, 2024, 2025, the Company had $4.6 $4.67 billion in outstanding debt, reflecting a decrease an increase of approximately $300 $100 million versus December 31, 2023. 2024.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
During the years ended December 31, 2024, 2023 2025, 2024 and 2022, 2023, the Company recorded non-cash impairment charges related to goodwill and indefinite-lived intangibles of $340 million, $345 million, $339 million and $474 $339 million, respectively.
Read it in 10-K Feb 13, 2026 at sec.gov
Quiet changesRisk Factors
Although the Company has long-established relationships with many customers, the Company generally does not have any long-term supply or binding contracts or guarantees of minimum purchases with its largest customers.
Read it in 10-K Feb 13, 2026 at sec.gov
Quiet changesRisk Factors
In addition, if If the Company is unable to timely reduce its level of indebtedness, the Company will be subject to increased demands on its cash resources, which could decrease its collateral coverage ratios, increase its leverage ratios, lower its credit ratings, result in a breach of covenants or otherwise adversely affect the business and financial results of the Company going forward.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
The Company is actively advancing the strategic priorities identified through its comprehensive capability assessment completed in 2023. These priorities are based on a clear set of “where to play” and “how to win” strategic choices with the goal of improving the Company’s top line, expanding margins and improving cash flows with a new operating model, critical talent upgrades and a culture redesign.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
Execution of these strategic imperatives, in combination with other initiatives aimed to build operational excellence, will better position the Company for long-term sustainable growth. One such initiative is the organizational Realignment
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
Plan, announced in 2024, which was designed to strengthen the Company’s front-end commercial capabilities, such as consumer understanding and brand communication, in support of the “where to play” and “how to win” strategies the Company initiated in 2023. Actions under the Realignment Plan were implemented by the end of fiscal year 2025.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
Further building on the Company’s turnaround strategy, the Company announced the Productivity Plan in December 2025. The Productivity Plan is designed to further simplify processes, streamline overhead and redirect resources to the highest-value activities. See Business in Item 1 for additional information on these initiatives.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
The current U.S. presidential administration has announced and/or imposed a series of new tariffs on foreign imports into the U.S., including without limitation significant tariffs on products manufactured in China. Tariffs on imports into the U.S., most significantly from China, and any retaliatory tariffs on exports from the U.S. to other countries, have increased costs for the Company and could impact the level of trade between the U.S. and its various trading partners around the globe in general.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
We believe that the Company is well-positioned to respond to the current tariff environment, primarily because the Company maintains a significant U.S. manufacturing presence of 15 production facilities and manufacturers, in the U.S. and two of its facilities in Mexico, products representing over half of the Company’s U.S. revenues that are not presently subject to the recently announced U.S. tariffs. This manufacturing presence is expected to provide a competitive advantage to the Company in certain categories where its competitors are exposed to import tariffs. The Company also has a scaled, centralized procurement team that is proficient in sourcing raw materials and finished products from over 50 countries around the world.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
The Company incurred incremental cash tariff cost of approximately $174 million in 2025 due to the currently announced and imposed tariffs as well as retaliatory tariffs on U.S. exports, prior to any offsetting impact from mitigating actions. There will be a timing difference between the operating cash outflow and the recognition of cost of products sold arising from the tariffs. As a result, the Company recognized approximately $114 million of incremental costs of products sold in the Consolidated Statement of Operations in 2025. The Company continues to deploy a mitigation strategy designed to offset the impact of this tariff exposure through a number of actions, including pricing, productivity and in some cases relocation of manufacturing. At this time, it is difficult to predict the rate or duration of these tariffs, and there can be no assurance as to the extent to which the Company will be able to offset the impact through mitigation actions. Additional tariffs or further increases to the U.S. tariffs, retaliatory actions taken by other countries, or failure to effectively deploy the Company’s mitigation plans could have a significant negative impact on the Company.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
During the fourth quarter of 2025, Moody’s further downgraded the Company’s senior unsecured debt rating to “B2”, without any further impact to the interest rates on any of the Company’s senior notes, as the Company has reached the maximum provision on the affected bonds.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
The Company’s $1.00 billion Credit Revolver matures in August 2027. Under the Credit Revolver, the Company may borrow funds on a variety of interest terms. The Credit Revolver agreement (i) requires the Company to satisfy financial covenants testing the Company’s Collateral Coverage Ratio and Total Net Leverage Ratio (each further defined in the Credit Revolver, as amended), (ii) requires the Company and certain of its domestic and foreign subsidiaries (the “Guarantors”) to guaranty Company obligations under the Credit Revolver and (iii) requires the Company and other Guarantors to grant a lien and security interest in certain assets consisting of eligible accounts receivables, eligible inventory, eligible equipment and eligible intellectual property, and all products and proceeds of the foregoing, subject to certain limitations.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
In accordance with the terms of the Credit Revolver, the Total Net Leverage Ratio covenant, is scheduled to decrease as of the last day of the fiscal quarter ending September 30, 2026 and to continue at such level for each fiscal quarter
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
ending thereafter during the remaining term of the Credit Revolver. The Company’s ability to continue to comply with the Total Net Leverage Ratio covenant is dependent upon the Company’s future operating and financial performance, which may be affected by economic conditions and other factors beyond our control. A failure to maintain the Company’s financial covenants and to subsequently remedy a default would impair its ability to borrow under the Credit Revolver and, absent a waiver of such default by the lenders under the Credit Revolver or an amendment or replacement of the Credit Revolver with alternative financing, potentially subject the Company to cross-default and acceleration provisions in its debt documents, which would have a significant adverse effect on the Company’s business, financial condition and operating results. While the Company would pursue refinancing the Credit Revolver with a new or amended borrowing facility should such action be necessary, there can be no assurance regarding the availability of such a new or amended facility on terms favorable to the Company or at all.
Read it in 10-K Feb 13, 2026 at sec.gov
RemovedMD&A
Following a comprehensive assessment of key capabilities, starting in the second quarter of 2023, the leadership team began implementing an integrated set of new “where to play” and “how to win” strategies designed to enable the Company to leverage the scale of the portfolio, while further building upon its operational foundation and strengthening its front-end capabilities.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
The Company is implementing this strategy while continuing to address key challenges such as shifting consumer preferences and behaviors; a highly competitive operating environment; a rapidly changing retail and consumer landscape; continued macroeconomic and geopolitical volatility; a soft macro backdrop; significant inflationary pressures on consumers and an evolving regulatory landscape.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
Execution of these strategic imperatives, in combination with other initiatives aimed to build operational excellence, will better position the Company for long-term sustainable growth. One such initiative is Project Ovid which entails a multi-year, customer centric supply chain initiative which has transformed the Company’s go-to-market capabilities in the U.S., improving customer service levels and driving operational efficiencies. Project Ovid optimized the Company’s distribution network in 2022 and 2023 by creating a single integrated supply chain from 23 business-unit-centric supply chains. The initiative reduced administrative complexity, improved inventory and invoicing workflow for our customers and enhanced product availability for consumers through omni-channel enablement. This new operating model continues to drive efficiencies by better utilizing the Company’s transportation and distribution network and consolidating the number of overall distribution sites.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
In May 2023, the Company announced a restructuring and cost savings initiative that was intended to simplify and streamline its North American distribution network (the “Network Optimization Project”) in order to improve the Company’s cost structure and operating margins while maintaining focus on customer and consumer fulfillment. The Network Optimization Project incorporated a variety of initiatives, including a reduction in the overall number of distribution centers, an optimization of distribution by location, and completion of select automation investments intended to further streamline the Company’s cost structure and to maximize operating performance. These actions were substantially implemented by the end of 2024.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
In January 2023, the Company announced a restructuring and savings initiative (“Project Phoenix”) that was intended to strengthen the Company by leveraging its scale to further reduce complexity, streamline its operating model and drive operational efficiencies. The Company commenced reducing headcount during the first quarter of 2023. Project Phoenix incorporated a variety of initiatives designed to simplify the organizational structure, streamline the Company’s real estate portfolio, centralize the Company’s supply chain functions, transition to a unified One Newell go-to-market model in key international geographies, and otherwise reduce overhead costs. These actions were substantially implemented by the end of 2023.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
In January 2024, the Company announced an organizational realignment (“Realignment Plan”), which was designed to strengthen the Company’s front-end commercial capabilities, such as consumer understanding and brand communication, in support of the “where to play” and “how to win” strategies the Company unveiled in June of 2023. In addition to improving accountability, the Realignment Plan was designed to unlock operational efficiencies and cost savings, reduce complexity and free up funds for reinvestment. As part of the Realignment Plan, the Company has made several operating model changes, which entailed: standing up a cross-functional brand management organization, realigning business unit finance to fully support the new global brand management model, further simplifying and standardizing regional go-to-market organizations, and centralizing domestic retail sales teams, the digital technology team, business-aligned accounting personnel, the Manufacturing Quality team, and the Human Resources functions into the appropriate center-led teams to drive standardization, efficiency and scale with a One Newell approach. The Company has also further optimized the Company’s real estate footprint and pursued other cost reduction initiatives. These actions were primarily implemented by the end of 2024. Remaining actions, subject to applicable local law and consultation requirements, are expected to be implemented by the end of fiscal year 2025.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
The Company continues to be impacted by soft global demand, major retailers’ focus on tight control over inventory levels, inflationary pressures, fluctuating interest rates and indirect impacts from geopolitical conflicts. These collective macroeconomic trends, the duration or severity of which are highly uncertain, are rapidly changing the retail and consumer landscape and negatively impacted the Company’s operating results, cash flows and financial condition during 2024 and are to some degree expected to persist into 2025.
Read it in 10-K Feb 14, 2025 at sec.gov
RewordedMD&A
Increase (Decrease) 2025 2024 2023 2022 2024 2023 Cash provided by (used in) operating activities $ 264 $ 496 $ 930 $ (272) $ (434) $ 1,202 (232) Cash provided by (used in) used in investing activities (164) (151) (199) 343 48 (542) (13) Cash used in financing activities (101) (451) (664) (232) 213 (432) 350 Exchange rate effect on cash, cash equivalents and restricted cash 2 (36) (9) (13) (27) 4 38 Increase (decrease) in cash, cash equivalents and restricted cash $ 1 $ (142) $ 58 $ (174) $ (200) $ 232 143
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
A hypothetical 10% reduction in the forecasted revenue earnings before interest, taxes, depreciation and residual (excess) cash flows amortization used in the excess earnings method applied in determining discounted cash flows to estimate the fair value of to the tradename Commercial reporting unit would have resulted in an incremental impairment charge on the H&CS segment of $22 approximately $131 million against its goodwill carrying value of $747 million.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
In November 2024, May 2025, the Company completed a registered public the offering and sale of $750 million $1.25 billion of aggregate principal amount of 6.375% 8.500% senior notes due 2030 2028 (the “2030 “2028 Notes”) and $500 million of aggregate principal amount of 6.625% senior notes due 2032 (the “2032 Notes”) (collectively the “Notes”) and received proceeds of approximately $1.24 $1.23 billion, net of fees and expenses paid.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Years Ended December 31, (in millions) 2023 2022 Pension settlement costs (See Footnote 11) $ 126 $ — Gain 2025 2024 (Gain) loss on disposition of businesses (See Footnote 2) — (136) and investments (a) $ (12) $ 2 Foreign exchange losses, net (See Footnote 10) 22 47 (b) 10 8 Discount on factored receivables and other, net 27 8 8 $ 175 6 $ (81) 18
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
(a)Restructuring-related (b)Restructuring-related costs reported in cost of products sold and selling, general and administrative expenses (“SG&A”) and in impairment of goodwill, intangibles and other assets for 2024 2025 were $36 million, $13 $4 million and $8 $24 million, respectively, and primarily relate to facility closures. closures associated with the Realignment Plan and various discrete initiatives as well as previously disclosed but substantially completed restructuring activities.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The decline was in operating results is primarily due to lower gross profit of $26 $116 million, caused by resulting from unfavorable fixed cost leverage associated with lower sales volume volume, additional tariffs and inflation, partially offset by gross productivity, favorable pricing and savings from restructuring actions and absence of a non-cash impairment charge of $22 million recorded in the prior year. productivity.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
At December 31, 2024, 2025, the Company had $40 million of outstanding borrowings under the Credit Revolver and approximately $35 $37 million of outstanding standby letters of credit issued against the Credit Revolver, with Revolver and $130 million of outstanding borrowings under the Credit Revolver resulting in a net availability of approximately $925 $685 million.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The Company classifies the proceeds received from the sales of accounts receivable to the financial institutions as an operating cash flow and collections of accounts receivables not yet submitted remitted to the financial institutions as financing cash flow in the Consolidated Statements of Cash Flows. Flows, and such collections are classified as restricted cash (included in prepaid expenses and other current assets) on the Company’s Consolidated Balance Sheets.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
(a)Restructuring-related Restructuring-related costs reported in cost of products sold and selling, general and administrative expenses (“SG&A”) sold, SG&A and in impairment of goodwill, intangibles and other assets for 2024 were $36 million, $13 million and $8 million, respectively, and primarily relate to facility closures. closures associated with previously disclosed but substantially completed restructuring activities, as well as other discrete initiatives.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Years Ended December 31, (in millions) 2025 2024 2023 $ Change Impairment of goodwill and intangible assets (See Footnotes 1 and 7) (a) $ 340 $ 345 $ 339 $ 6 (5) Restructuring (See Footnote 4) and restructuring-related (a) (b) 90 102 194 (92) (12) Transaction costs and other (c) 39 12 46 (34) 27
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Factored Outstanding receivables sold under the Customer Receivables Purchase Agreement totaled approximately $270 million at both December 31, 2024 were approximately $270 million, an increase of approximately $30 million from December 31, 2023. 2025 and 2024.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
During the fourth quarter of 2024, 2025, as a result of the Company’s annual impairment testing, the Company recorded a an aggregate non-cash impairment charge of $85 $340 million related to one tradename two tradenames in the H&CS segment and one in the L&D segment, as the carrying value values of the tradename tradenames exceeded its their fair value. values.
Read it in 10-K Feb 13, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NWL/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.